Detalhe da pesquisa
1.
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.
Mult Scler
; 30(3): 336-344, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38247138
2.
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(2): 667-676, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36319902
3.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36166174
4.
Correction to: Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(3): 1135, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36348171
5.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630312
6.
Shared decision making in the treatment of multiple sclerosis: A consensus based on Delphi methodology.
Mult Scler Relat Disord
; 70: 104465, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36565557
7.
Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort.
Mult Scler Relat Disord
; 70: 104485, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36610362
8.
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Mult Scler J Exp Transl Clin
; 9(1): 20552173231154712, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36846108
9.
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Mult Scler Relat Disord
; 79: 104935, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37634468
10.
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231205444, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37854639
11.
Rebound activity after fingolimod cessation: A case - control study.
Mult Scler Relat Disord
; 57: 103329, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35158443
12.
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina.
Mult Scler Relat Disord
; 58: 103483, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35032883
13.
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM.
J Neurol
; 269(4): 2073-2079, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34491406
14.
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.
Mult Scler Relat Disord
; 58: 103466, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34929456
15.
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Mult Scler Relat Disord
; 68: 104104, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36057175
16.
Use of cannabis in patients with multiple sclerosis from Argentina.
Mult Scler Relat Disord
; 51: 102932, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33848817
17.
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina.
Mult Scler J Exp Transl Clin
; 7(3): 20552173211032334, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34434560
18.
Aggressive multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
J Clin Neurosci
; 89: 360-364, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34088579
19.
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM.
Mult Scler Relat Disord
; 51: 102886, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33744758
20.
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).
Mult Scler Relat Disord
; 49: 102742, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33454601